These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24267616)

  • 21. Airway allergen exposure stimulates bone marrow eosinophilia partly via IL-9.
    Sitkauskiene B; Rådinger M; Bossios A; Johansson AK; Sakalauskas R; Lötvall J
    Respir Res; 2005 Apr; 6(1):33. PubMed ID: 15823208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of IL-4/IL-13 does not enhance the efficacy of allergen immunotherapy in murine allergic airway inflammation.
    Gogishvili T; Hahn C; Meinhard J; Hohaus A; Erb K; Sebald W; Bröcker EB; Grunewald SM
    Int Arch Allergy Immunol; 2007; 142(2):165-74. PubMed ID: 17077644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge.
    Gaspar Elsas MI; Joseph D; Elsas PX; Vargaftig BB
    Am J Respir Cell Mol Biol; 1997 Oct; 17(4):404-13. PubMed ID: 9376115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation.
    Garlisi CG; Kung TT; Wang P; Minnicozzi M; Umland SP; Chapman RW; Stelts D; Crawley Y; Falcone A; Myers JG; Jones H; Billah MM; Kreutner W; Egan RW
    Am J Respir Cell Mol Biol; 1999 Feb; 20(2):248-55. PubMed ID: 9922215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells.
    Itakura A; Kikuchi Y; Kouro T; Ikutani M; Takaki S; Askenase PW; Takatsu K
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():8-16. PubMed ID: 16772721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice.
    Szyszko EA; Skarstein K; Jonsson R; Brokstad KA
    Autoimmunity; 2011 Aug; 44(5):415-26. PubMed ID: 21332424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice.
    Broide D; Schwarze J; Tighe H; Gifford T; Nguyen MD; Malek S; Van Uden J; Martin-Orozco E; Gelfand EW; Raz E
    J Immunol; 1998 Dec; 161(12):7054-62. PubMed ID: 9862743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice.
    Nagai H; Yamaguchi S; Maeda Y; Tanaka H
    Clin Exp Allergy; 1996 Jun; 26(6):642-7. PubMed ID: 8809421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged eosinophil production after allergen exposure in IFN-gammaR KO mice is IL-5 dependent.
    Zhao LL; Lötvall J; Lindén A; Tomaki M; Sjöstrand M; Bossios A
    Scand J Immunol; 2008 May; 67(5):480-8. PubMed ID: 18405326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An agonistic anti-BTLA mAb (3C10) induced generation of IL-10-dependent regulatory CD4+ T cells and prolongation of murine cardiac allograft.
    Uchiyama M; Jin X; Matsuda H; Bashuda H; Imazuru T; Shimokawa T; Yagita H; Niimi M
    Transplantation; 2014 Feb; 97(3):301-9. PubMed ID: 24448587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrier.
    Vallera DA; Schmidberger H; Buchsbaum DJ; Everson P; Snover DC; Blazar BR
    Cancer Res; 1991 Apr; 51(7):1891-7. PubMed ID: 2004372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow PDGFRα+Sca-1+-enriched mesenchymal stem cells support survival of and antibody production by plasma cells in vitro through IL-6.
    Kayaba A; Itoh-Nakadai A; Niibe K; Shirota M; Funayama R; Sugahara-Tobinai A; Wong YL; Inui M; Nakayama K; Takai T
    Int Immunol; 2018 May; 30(6):241-253. PubMed ID: 29529192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.